Modern patient treatment usually demands the use of non-invasive imaging techniques to evaluate the anatomy, function, or molecular-biological states of patients or research participants. Such imaging techniques can be used alone to provide anatomical or molecular information, or they can be coupled to provide "anato-metabolic" data. In order to enhance diagnostic accuracies, patient comfort, and diagnostic confidence, hybrid imaging refers to image acquisitions on systems that physically integrate complementary imaging modalities. Leading thinkers in clinical research were responsible for the physical fusion of traditionally separate imaging modalities, and it profited from technology advancements that made it possible, for instance, to operate PET and MR next to one another physically. The development of several hybrid imaging systems for use in this evaluation is covered at key points. The development of several hybrid imaging technologies for use in small-animal research and clinical practise is covered in this review's milestones. The introduction of methodological concepts that profit from the availability of complementary anatomical and biological information, such as new types of image reconstruction and data correction schemes, as well as technological advancements that aided in the adoption of hybrid imaging are both given special attention. Hybrid imaging's ultimate objective is to offer helpful, complementary, and quantitative data during patient evaluation. Hybrid imaging also makes it possible to examine illnesses on a multi-parametric level, which will enable us to learn more about the underlying causes of the many conditions that now account for a significant portion of healthcare spending.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico